Zyus Life Sciences Aktie - ZYUS

Professionelle Tools für Privatanleger.

Premium

Current Price

0,77

Gebot

0,75

Fragen

0,77

Volumen

0,00 Tagesbereich 0,00

0,00 52-Wochen-Bereich 0,00

Marktkapitalisierung

54,552M

Handelsende

0,77

Handelsbeginn

Letzte Trade

Letzter Handelszeitpunkt

Finanzvolumen

VWAP

Durchschnittliches Volumen (3 Mio.)

Ausgegebene Aktien

70.847.000

Dividendenrendite

Kurs-Gewinn-Verhältnis

-1,28

Gewinn pro Aktie (EPS)

-0,6

Erlöse

351k

Nettogewinn

-42,59M

Sektor

Pharmaceutical Preparations

Branche

Oil And Gas Field Expl Svcs

Website

www.zyus.com

Hauptsitz

Toronto, Ontario, Can

Gegründet

2023

Zyus Life Sciences Corporation is listed in the Pharmaceutical Preparations sector of the TSX Venture Börse with ticker ZYUS. The last closing price for Zyus Life Sciences was $0,77. Over the last year, Zyus Life Sciences shares have traded in a share price range of $ 0,00 to $ 0,00.

Zyus Life Sciences currently has 70.847.000 shares in issue. The market capitalisation of Zyus Life Sciences is $54,55 million. Zyus Life Sciences has a price to earnings ratio (PE ratio) of -1.28.

INSERTING and REPLACING ZYUS Life Sciences Corporation to Present at Sidoti Virtual Investor Conference May 8-9

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Insert as subheadline: NOT FOR DISTRIBUTION TO U.S...

ZYUS Life Sciences Corporation to Present at Sidoti Virtual Investor Conference May 8-9

ZYUS Life Sciences Corporation (“ZYUS” or the “Company”) (TSXV: ZYUS) is pleased to announce that Brent Zettl, President and CEO of ZYUS, will...

ZYUS Life Sciences Receives United States Patent No. 11,963,943 Covering Pain Management

ZYUS Receives Patent from United States Patent and Trademark Office (“USPTO”) Supporting ZYUS’ Lead Drug Candidate ZYUS Life Sciences Corporation...

ZYUS Strengthens Expertise of Clinical Advisory Committee with the Appointment of Dr. Hance Clarke

Dr. Clarke Joins ZYUS’ Clinical Advisory Committee, Bringing Extensive Expertise in Healthcare and Pain Management ZYUS Life Sciences Corporation...

ZYUS Strengthens Leadership Team with Appointment of Vice President of Clinical Research

Scott Livingstone brings extensive healthcare expertise and strategic leadership to ZYUS’ experienced team ZYUS Life Sciences Corporation (the...

ZYUS Life Sciences Corporation Announces Phase 2 Clinical Trial Evaluating Trichomylin® Softgel Capsules for Advanced Cancer Pain Management

Evaluating Efficacy, Safety, and Tolerability in Patients with Moderate to Severe Cancer-Related Pain ZYUS Life Sciences Corporation ("ZYUS" or...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

ZYUS - Frequently Asked Questions (FAQ)

What is the current Zyus Life Sciences share price?

The current share price of Zyus Life Sciences is $ 0,77

How many Zyus Life Sciences shares are in issue?

Zyus Life Sciences has 70.847.000 shares in issue

What is the market cap of Zyus Life Sciences?

The market capitalisation of Zyus Life Sciences is CAD 54,55M

What is the 1 year trading range for Zyus Life Sciences share price?

Zyus Life Sciences has traded in the range of $ 0,00 to $ 0,00 during the past year

What is the PE ratio of Zyus Life Sciences?

The price to earnings ratio of Zyus Life Sciences is -1,28

What is the cash to sales ratio of Zyus Life Sciences?

The cash to sales ratio of Zyus Life Sciences is 154

What is the reporting currency for Zyus Life Sciences?

Zyus Life Sciences reports financial results in CAD

What is the latest annual turnover for Zyus Life Sciences?

The latest annual turnover of Zyus Life Sciences is CAD 351k

What is the latest annual profit for Zyus Life Sciences?

The latest annual profit of Zyus Life Sciences is CAD -42,59M

What is the registered address of Zyus Life Sciences?

The registered address for Zyus Life Sciences is 3400-22 ADELAIDE STREET W, TORONTO, ONTARIO, M5H 4E3

What is the Zyus Life Sciences website address?

The website address for Zyus Life Sciences is www.zyus.com

Which industry sector does Zyus Life Sciences operate in?

Zyus Life Sciences operates in the OIL AND GAS FIELD EXPL SVCS sector

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
AAAAAuralite Investments Inc	$ 0,265 (0,00%)	0
AAA.PFirst Tidal Acquisition Corp	$ 0,055 (0,00%)	0
AAAlba Minerals Ltd	$ 0,03 (0,00%)	0
A.HArmor Minerals Inc	$ 0,355 (0,00%)	0
AArmor Minerals Inc	$ 0,45 (0,00%)	0
AAAAAuralite Investments Inc	$ 0,265 (0,00%)	0
AAA.PFirst Tidal Acquisition Corp	$ 0,055 (0,00%)	0
AAAlba Minerals Ltd	$ 0,03 (0,00%)	0
A.HArmor Minerals Inc	$ 0,355 (0,00%)	0
AArmor Minerals Inc	$ 0,45 (0,00%)	0
AAAAAuralite Investments Inc	$ 0,265 (0,00%)	0
AAA.PFirst Tidal Acquisition Corp	$ 0,055 (0,00%)	0
AAAlba Minerals Ltd	$ 0,03 (0,00%)	0
A.HArmor Minerals Inc	$ 0,355 (0,00%)	0
AArmor Minerals Inc	$ 0,45 (0,00%)	0

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Zyus Life Sciences Corporation (ZYUS)

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Über Zyus Life Sciences Corporation

ZYUS Neueste Nachrichten

INSERTING and REPLACING ZYUS Life Sciences Corporation to Present at Sidoti Virtual Investor Conference May 8-9

ZYUS Life Sciences Corporation to Present at Sidoti Virtual Investor Conference May 8-9

ZYUS Life Sciences Receives United States Patent No. 11,963,943 Covering Pain Management

ZYUS Strengthens Expertise of Clinical Advisory Committee with the Appointment of Dr. Hance Clarke

ZYUS Strengthens Leadership Team with Appointment of Vice President of Clinical Research

ZYUS Life Sciences Corporation Announces Phase 2 Clinical Trial Evaluating Trichomylin® Softgel Capsules for Advanced Cancer Pain Management

ZYUS Life Sciences Corporation Announces Positive Phase I Clinical Trial Results for Trichomylin® Softgels

ZYUS Life Sciences Corporation Announces New Director of Investor Relations and Capital Markets

ZYUS Life Sciences Corporation Obtains Health Canada Security Clearance for New Board Member Wayne Brownlee

ZYUS Life Sciences Strengthens Board of Directors with the Appointment of Wayne Brownlee

INSERTING and REPLACING ZYUS Life Sciences Corporation to Present at Sidoti Virtual Investor Conference May 8-9

ZYUS Life Sciences Corporation to Present at Sidoti Virtual Investor Conference May 8-9

ZYUS Life Sciences Receives United States Patent No. 11,963,943 Covering Pain Management

ZYUS - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Zyus Life Sciences Corporation (ZYUS) Börsenkurse

Zyus Life Sciences Corporation (ZYUS)

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Über Zyus Life Sciences Corporation

ZYUS Neueste Nachrichten

INSERTING and REPLACING ZYUS Life Sciences Corporation to Present at Sidoti Virtual Investor Conference May 8-9

ZYUS Life Sciences Corporation to Present at Sidoti Virtual Investor Conference May 8-9

ZYUS Life Sciences Receives United States Patent No. 11,963,943 Covering Pain Management

ZYUS Strengthens Expertise of Clinical Advisory Committee with the Appointment of Dr. Hance Clarke

ZYUS Strengthens Leadership Team with Appointment of Vice President of Clinical Research

ZYUS Life Sciences Corporation Announces Phase 2 Clinical Trial Evaluating Trichomylin® Softgel Capsules for Advanced Cancer Pain Management

ZYUS Life Sciences Corporation Announces Positive Phase I Clinical Trial Results for Trichomylin® Softgels

ZYUS Life Sciences Corporation Announces New Director of Investor Relations and Capital Markets

ZYUS Life Sciences Corporation Obtains Health Canada Security Clearance for New Board Member Wayne Brownlee

ZYUS Life Sciences Strengthens Board of Directors with the Appointment of Wayne Brownlee

INSERTING and REPLACING ZYUS Life Sciences Corporation to Present at Sidoti Virtual Investor Conference May 8-9

ZYUS Life Sciences Corporation to Present at Sidoti Virtual Investor Conference May 8-9

ZYUS Life Sciences Receives United States Patent No. 11,963,943 Covering Pain Management

ZYUS - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS